Anti-Amyloid Beta Reference Antibody (lecanemab)
分享
收藏
推荐应用
产品介绍
Lecanemab (Mouse IGG2a) (Mab158) 是一种靶向可溶性 β-amyloid 的单克隆抗体，具有减缓认知功能下降的潜力。Lecanemab (Mouse IGG2a) 的可变区与 Lecanemab 一致，而恒定区为 Mouse IGG2a 序列。Lecanemab (Mouse IGG2a) 几乎完全消除星形胶质细胞中的 Aβ 积累，并拯救神经元免受 Aβ 诱导的细胞死亡。Lecanemab (Mouse IGG2a) 在阿尔茨海默病研究领域具有潜在价值 。
产品性质
产品特色
For Powder, reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
应用案例
本产品仅用作科学研究！
Anti-Amyloid Beta Reference Antibody (lecanemab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
The purity of Anti-Amyloid Beta Reference Antibody (lecanemab) is 99.7%, determined by SEC-HPLC.
Immobilized Aβ42/Aβ40 at 2 ug/mL can bind Anti-Amyloid Beta Reference Antibody (lecanemab), EC50=0.003559/0.002915 ug/mL.
存储条件
-80°C for 2 years under sterile conditions；-20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles.
COA
已发表文献
相关产品
联系我们
